Next week (26th to 30th), four corporations, including GC Genome, will conduct subscription and demand forecasting for their initial public offering (IPO). GC Genome and Lincsolution are preparing for general subscription, while Dowooinsys and GFC Life Science will engage in demand forecasting.

According to the financial investment industry on the 25th, GC Biopharma's diagnostic subsidiary GC Genome will conduct a subscription for general investors from the 29th to 30th.

Established in 2013, GC Genome is engaged in clinical genome analysis. It provides more than 300 types of genetic testing services, including health check-up tests, prenatal and newborn tests, cancer precision diagnosis tests, and genetic rare disease precision diagnosis tests. It has over 900 client hospitals.

Lincsolution will also conduct subscriptions on the 27th and 28th. Established in 2015, Lincsolution is a 3D printer corporation. Typically, 3D printers require dedicated materials, but the strength of Lincsolution's products is that they can use materials from other companies.

Dowooinsys and GFC Life Science will engage in demand forecasting. Dowooinsys, established in 2010, develops and manufactures ultra-thin tempered glass (UTG) for electronic devices, including foldable smartphones. The demand forecasting will be conducted from the 26th to 30th, with a hoped-for public offering price of 29,000 won to 32,000 won.

GFC Life Science will initiate demand forecasting from the 30th until the 9th of next month. The hoped-for public offering price is 12,300 won to 15,300 won. GFC Life Science is engaged in the cosmetic material and original development manufacturing (ODM) business.

Recently, newly listed corporations on the KOSDAQ market have shown consecutive strength, increasing interest in public offerings. ImmuneOncia, Biobijou, and IntoCell, all listed last week, saw their stock prices rise more than twice compared to the public offering price on the first day.

GC Genome and Lincsolution are scheduled to be listed on the KOSDAQ market on the 11th and 10th of next month, respectively.